Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-08-21

Clinical Trial Update: Post Operative Delirium Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating postoperative delirium sponsored by the University of Kansas Medical Center has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Delirium | Phase 1, Phase 2 | Status: WITHDRAWN